🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementI literally cannot eat more than 3 bites help

I literally cannot eat more than 3 bites help

WendyG_ATL Tue, Apr 21, 2026 at 2:19 AM 11 replies 719 viewsPage 1 of 3
WendyG_ATL
Member
1,023
5,678
Apr 2024
Georgia
Apr 21, 2026 at 2:19 AM#1

Nausea arrived on day two of each dose step, lasted about four days, and disappeared entirely by the second week — until the step where it did not.

What would genuinely help is knowing whether holding at a lower dose for longer actually reduces total side-effect burden or just spreads it out.

I would rather have one careful answer than five confident ones.

43 13Dr.SurgeonPGH, rachel_ABQ, traveltech_sara and 40 others
Reply Quote Save Share Report
NeuroNate
Senior Member
2,890
16,789
Dec 2023
Chicago, IL
Apr 21, 2026 at 4:32 AM#2

Answering the narrow version, because the broad one does not have a single answer. The practical protocol is dull and it works: smaller meals, stop eating at the first sign of fullness rather than at the end of the plate, drop the fat fraction of meals in the two days after dosing, and do not lie down straight after eating. Most of what people call unmanageable nausea is a meal-size and meal-composition problem interacting with a stomach that is emptying slowly.

42 12wendy_avl, jason_paloalto, Dr.LeslieOBGYN and 39 others
Reply Quote Save Share Report
NurseKim_ATL
Senior Member
1,678
7,234
Feb 2024
Atlanta, GA
Apr 21, 2026 at 6:45 AM#3
NeuroNate said:
The practical protocol is dull and it works: smaller meals, stop eating at the first sign of fullness rather than at the end of the plate, drop the…

NeuroNate has the substance of this right. The condition it depends on is worth stating. The meal advice is right and incomplete without the hydration point. People stop drinking because drinking makes them feel full, then attribute dehydration symptoms to the drug.

Last edited: Apr 21, 2026 at 11:45 AM
41 11ingrid_STO, pete_nash, hank_denver and 38 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
TinaHashiRN
Member
345
1,567
Sep 2024
Raleigh, NC
Apr 21, 2026 at 8:58 AM#4
WendyG_ATL said:
Nausea arrived on day two of each dose step, lasted about four days, and disappeared entirely by the second week — until the step where it did not.

This matches mine closely enough to be worth saying so. Holding genuinely reduces total burden rather than redistributing it, because the gastric-emptying component adapts. Receptor-level tachyphylaxis to the delayed-emptying effect develops over weeks while the central appetite effect persists, so the same dose is materially more comfortable at week six than at week two. A slower ladder therefore reaches the same dose with less cumulative nausea, not the same nausea spread thinner.

Ask again with the specifics and you will get a better answer than this one.

40 10Admin, Dr.Martinez, mike_mod and 37 others
Reply Quote Save Share Report
julia.endo
Senior Member
1,890
9,012
Feb 2024
Cincinnati, OH
Apr 21, 2026 at 10:10 PM#5

Clinical perspective, offered as context rather than as advice. It is worth asking what the claim would look like if it were false. If nothing would look different, it is not a claim about the world and no amount of discussion will settle it.

I would rather be corrected than agreed with, if it comes to it.

39 9chris_chi24, tampaLisa73, KarenAZ_mom and 36 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register